Andrew is Executive Chairman at CRISM Therapeutics, a platform drug delivery technology company. The Company’s lead product, ChemoSeed is for the treatment of brain tumour. Future indications may include pancreatic, prostate, bladder and breast cancers. Experience & History Andrew has over 30 years of commercial experience in the Diagnostics and Life Sciences industry. His previous […]
Chris McConville (Professor of Biomedical Innovation at Ulster University) leads a research group with an internationally recognised portfolio in the fields of drug formulation, delivery and pharmaceutical engineering, and has impactful collaborative links with academic, clinical and industrial partners. With a focus on implantable devices and nanotechnology for the improvement of cancer treatment, recent work […]
Gerry is a consultant to growth companies seeking strategic advice or funding for expansion. He was a non-executive director of Spectral MD Holdings Ltd (subsequently renamed Spectral AI, Inc.) a medical technology company quoted on AIM between June 2021 and September 2023. Experience & History Gerry is a consultant to growth companies seeking strategic advice […]